<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id><journal-id journal-id-type="pmc">plosbiol</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Biology</journal-title></journal-title-group><issn pub-type="ppub">1544-9173</issn><issn pub-type="epub">1545-7885</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PBIOLOGY-D-10-00545</article-id><article-id pub-id-type="doi">10.1371/journal.pbio.1001056</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Unsolved Mystery</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Neuroscience</subject>
            <subj-group>
              <subject>Cognitive neuroscience</subject>
              <subj-group>
                <subject>Consciousness</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Sensory perception</subject>
              <subj-group>
                <subject>Psychophysics</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Sensory systems</subject>
              <subj-group>
                <subject>Visual system</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Neurotransmitters</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Drugs and devices</subject>
            <subj-group>
              <subject>Neuropharmacology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Neurology</subject>
            <subj-group>
              <subject>Migraine</subject>
              <subject>Neuro-ophthalmology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Toxicology</subject>
            <subj-group>
              <subject>Neurotoxicology</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Neuroscience</subject>
          <subject>Pharmacology</subject>
          <subject>Neurological Disorders</subject>
        </subj-group>
      </article-categories><title-group><article-title>Visual Trails: Do the Doors of Perception Open
                    Periodically?</article-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Dubois</surname>
            <given-names>Julien</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>VanRullen</surname>
            <given-names>Rufin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Université de Toulouse, Centre de
                    Recherche Cerveau et Cognition, Université Paul Sabatier, Toulouse,
                    France</addr-line>
            </aff><aff id="aff2"><label>2</label><addr-line>Centre National de la Recherche Scientifique,
                    UMR5549, Faculté de Médecine de Purpan, Toulouse,
                    France</addr-line>
            </aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">jcrdubois@gmail.com</email></corresp>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <month>5</month>
        <year>2011</year>
      </pub-date><pub-date pub-type="epub">
        <day>10</day>
        <month>5</month>
        <year>2011</year>
      </pub-date><volume>9</volume><issue>5</issue><elocation-id>e1001056</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2011</copyright-year><copyright-holder>Dubois, VanRullen</copyright-holder><license><license-p>This is an open-access article distributed under
                the terms of the Creative Commons Attribution License, which permits unrestricted
                use, distribution, and reproduction in any medium, provided the original author and
                source are credited.</license-p></license></permissions><funding-group><funding-statement>EURYI (<ext-link ext-link-type="uri" xlink:href="http://www.esf.org/activities/euryi/awards/2007.html" xlink:type="simple">http://www.esf.org/activities/euryi/awards/2007.html</ext-link>) ANR
                        (<ext-link ext-link-type="uri" xlink:href="http://www.agence-nationale-recherche.fr/" xlink:type="simple">http://www.agence-nationale-recherche.fr/</ext-link>) 06JCJC-0154. The
                    funders had no role in study design, data collection and analysis, decision to
                    publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="4"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title/>
      <p>“Visual trailing” is a transient but dramatic disturbance of visual
                motion perception of unknown origin: the subject perceives a series of discrete
                stationary images trailing in the wake of otherwise normally moving objects.
                Although this phenomenon is most frequently encountered after ingestion of
                prescription and/or illicit drugs (most commonly with lysergic acid diethylamid, or
                LSD), it has also occasionally been reported following brain damage or neurological
                disorders. A quantitative account of visual trails is lacking; we argue that careful
                experimental investigation could potentially reveal how our brains update conscious
                visual perception in time.</p>
    </sec>
    <sec id="s2">
      <title>What Do Visual Trails Look Like?</title>
      <p>Ask any LSD user: they know the drug is taking effect when the “good
                trails” kick in. Trailing is a visual perceptual effect commonly experienced
                during LSD consumption and as a long-lasting side effect of the drug (hallucinogen
                persisting perception disorder) <xref ref-type="bibr" rid="pbio.1001056-Asher1">[1]</xref>–<xref ref-type="bibr" rid="pbio.1001056-Kawasaki1">[4]</xref>. LSD users perceive a series of discrete positive
                afterimages in the wake of moving objects, a percept that has been likened to a
                multiple-exposure stroboscopic photograph, somewhat akin to Etienne-Jules
                Marey's chronophotographs <xref ref-type="bibr" rid="pbio.1001056-Sacks1">[5]</xref> from 1880, or to more recent digital art produced in a few
                clicks (<xref ref-type="fig" rid="pbio-1001056-g001">Figure 1</xref>).</p>
      <fig id="pbio-1001056-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pbio.1001056.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Multiple-exposure stroboscopic photograph.</title>
          <p>This illustrates (inasmuch as possible with a static image) the perception
                        experienced during trailing.</p>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001056.g001" xlink:type="simple"/>
      </fig>
      <p>Trailing is a visual disturbance that has been observed under various conditions.
                While some authors use the terminology of LSD users <xref ref-type="bibr" rid="pbio.1001056-Asher1">[1]</xref>–<xref ref-type="bibr" rid="pbio.1001056-Abraham1">[3]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Kraus1">[6]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Schwartz1">[7]</xref>, others describe the
                phenomenon in more clinically suited terms: examples are “akinetopsia”
                    <xref ref-type="bibr" rid="pbio.1001056-Horton1">[8]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Tsai1">[9]</xref>,
                    “polyopia”<xref ref-type="bibr" rid="pbio.1001056-Tsai1">[9]</xref>, “palinopsia” <xref ref-type="bibr" rid="pbio.1001056-Kawasaki1">[4]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Hughes1">[10]</xref>–<xref ref-type="bibr" rid="pbio.1001056-Abert1">[13]</xref>, or “visual
                perseveration” <xref ref-type="bibr" rid="pbio.1001056-Hoffer1">[14]</xref>. In <xref ref-type="table" rid="pbio-1001056-t001">Table
                    1</xref>, we clarify the meaning of each of these terms (according to <xref ref-type="bibr" rid="pbio.1001056-Sacks1">[5]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Horton1">[8]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Zeki1">[15]</xref>–<xref ref-type="bibr" rid="pbio.1001056-Smith1">[21]</xref>). However, none
                of these terms precisely captures the specific elements of visual trails: they occur
                only for moving objects (unlike polyopia); moving objects are still perceived as
                moving (unlike akinetopsia); duplicate images are perceived only in the presence of
                real objects (unlike palinopsia); and, most importantly, visual trails are not mere
                streaks (<xref ref-type="bibr" rid="pbio.1001056-Ermentrout1">[22]</xref>), as would appear on a long-exposure photograph of moving
                objects (visual perseveration). Rather, trailing consists of a discrete series of
                snapshots of the moving object along its past trajectory, as if successive frames of
                a movie had been superimposed. These phenomenological features of trailing are
                clearly portrayed in the case reports that we collected (<xref ref-type="boxed-text" rid="pbio-1001056-box001">Box 1</xref>). The discreteness of the trailing
                percept, in particular, is one of its most characteristic, and most mysterious,
                aspects.</p>
      <table-wrap id="pbio-1001056-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001056.t001</object-id><label>Table 1</label><caption>
          <title>Glossary.</title>
        </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pbio-1001056-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001056.t001" xlink:type="simple"/><table>
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <td align="left" colspan="1" rowspan="1">TRAILING</td>
              <td align="left" colspan="2" rowspan="1">An object in motion is followed by a
                                discrete series of stationary images that slowly fade out along its
                                trajectory</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1">Our Definition</td>
              <td align="left" colspan="1" rowspan="1">How It Differs from Trailing</td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" colspan="1" rowspan="1">AKINETOPSIA</td>
              <td align="left" colspan="1" rowspan="1">An object in motion is not perceived as moving
                                continuously; rather, it is experienced as a series of stills</td>
              <td align="left" colspan="1" rowspan="1">The perception of motion is abolished and a single
                                frame can be seen at any one time</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">POLYOPIA</td>
              <td align="left" colspan="1" rowspan="1">Multiple images of an object (from two to 100 in
                                extreme cases) are perceived simultaneously</td>
              <td align="left" colspan="1" rowspan="1">Polyopia is not specific to objects in motion</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">VISUAL PERSEVERATION</td>
              <td align="left" colspan="1" rowspan="1">A positive afterimage persists after removal of an
                                object</td>
              <td align="left" colspan="1" rowspan="1">Visual perseveration for a moving object would leave a
                                blur in its wake, rather than discrete images</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">PALINOPSIA</td>
              <td align="left" colspan="1" rowspan="1">Similar to visual perseveration; some authors describe
                                a lag between the removal of the object and the onset of the
                                afterimage</td>
              <td align="left" colspan="1" rowspan="1">Same as visual perseveration, potentially with a gap
                                between the moving object and the perseverant tail</td>
            </tr>
          </tbody>
        </table></alternatives></table-wrap>
      <boxed-text id="pbio-1001056-box001" position="float">
        <sec id="s2a1">
          <title>Box 1. Selected Case Reports</title>
          <sec id="s2a1a">
            <title>Lysergic acid diethylamide (LSD)</title>
            <p>“[When asked] if they ever ‘saw any trails’,
                            [the subject] would wave a hand across the visual field and
                            say ‘Oh, you mean these?’ The subject could then describe a
                            trail of images of the moving hand, much like the frames of a piece of
                            motion picture film frozen in space long enough for the subject to see
                            them” <xref ref-type="bibr" rid="pbio.1001056-Abraham1">[3]</xref>.</p>
          </sec>
          <sec id="s2a1b">
            <title>Nefazodone</title>
            <p>“A 47-year-old man reported seeing streams of multiple, frozen
                            images trailing in the wake of moving objects. As soon as motion ceased,
                            the images collapsed into each other. He compared his vision to a scene
                            lit by a flashing strobe, except that stationary elements were perceived
                            normally. In fact, if nothing was in motion and he held perfectly still,
                            his vision was entirely normal. The moment anything moved, however, it
                            left a stream of static copies in its path. For example, while out for
                            an evening stroll, he saw a pack of identical dogs lined up behind his
                            West Highland terrier. Driving was impossible because he was confused by
                            multiple snapshots of cars, streets, and signs. Moving lights were
                            followed by a long comet tail” <xref ref-type="bibr" rid="pbio.1001056-Horton1">[8]</xref>.</p>
          </sec>
          <sec id="s2a1c">
            <title>Trazodone</title>
            <p>“He began to have numerous morning episodes of ‘strobe
                            images’. They were most apt to occur in dim illumination. He
                            described looking at the door of his bedroom and seeing multiple images
                            of the door ‘march’ across his field of vision when he
                            shifted his gaze to the bureau on the other side of the room. The false
                            images were intense, and he had many such episodes every morning, each
                            lasting 15 minutes or less” <xref ref-type="bibr" rid="pbio.1001056-Hughes1">[10]</xref>.</p>
          </sec>
          <sec id="s2a1d">
            <title>Mirtazapine</title>
            <p>“As she watched her husband walk past her, she saw multiple
                            afterimages of him as if he were leaving a visual trail. These
                            afterimages were less color intensive than the normal visual image,
                            slightly blurred, and faded away after 30 seconds to 1 minute. The
                            phenomenon repeated itself with most moving objects and was generally
                            more pronounced with objects in Ms. A's lateral visual
                            fields” <xref ref-type="bibr" rid="pbio.1001056-IhdeScholl1">[29]</xref>.</p>
          </sec>
          <sec id="s2a1e">
            <title>Topiramate</title>
            <p>“Ms. A reported seeing ‘picture in picture’ images,
                            like she was in a ‘discotheque’, or in a place with
                            stroboscopic lights. Those persistent ‘frozen pictures’
                            faded away after a few seconds. The phenomenon repeated itself with most
                            moving objects” <xref ref-type="bibr" rid="pbio.1001056-Fontenelle1">[11]</xref>.</p>
          </sec>
        </sec>
      </boxed-text>
    </sec>
    <sec id="s3">
      <title>Who Experiences Visual Trails?</title>
      <p>While LSD induces trailing <xref ref-type="bibr" rid="pbio.1001056-Asher1">[1]</xref>–<xref ref-type="bibr" rid="pbio.1001056-Abraham1">[3]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Kawasaki2">[23]</xref>, consumption of other hallucinogens like psilocin and
                mescaline has not been linked with such visual disturbances in the clinical
                literature (to our knowledge). Either their interaction with the receptors that
                mediate trailing is not as potent, or LSD acts at sites that other hallucinogens do
                not bind with (for a review of the pharmacology of hallucinogens, see <xref ref-type="bibr" rid="pbio.1001056-Nichols1">[24]</xref> and for LSD
                more specifically, see <xref ref-type="bibr" rid="pbio.1001056-Passie1">[25]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Hintzen1">[26]</xref>). Reports pertaining to the past use of illicit drugs
                are, however, poorly controlled (a good example is a report of illegal marijuana
                leading to trailing by Levi and Miller <xref ref-type="bibr" rid="pbio.1001056-Levi1">[27]</xref>, in which they explicitly
                acknowledge that their cases may be confounded by the presence of impurities in
                illegal marijuana, as well as by past use of LSD).</p>
      <p>A better understanding of the pharmacology of trailing may arise from the report of
                similar visual disturbances following the use of prescription drugs. The chemistry
                and dosage of prescription drugs is well controlled, which is not the case for
                illicit drugs. Nefazodone, for instance, is a recent antidepressant drug with
                multiple reports of episodes of visual trails as a side effect <xref ref-type="bibr" rid="pbio.1001056-Kraus1">[6]</xref>–<xref ref-type="bibr" rid="pbio.1001056-Horton1">[8]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Faber1">[28]</xref>. A closely related
                antidepressant drug, trazodone, can induce similar side effects <xref ref-type="bibr" rid="pbio.1001056-Hughes1">[10]</xref>; so can
                mirtazapine <xref ref-type="bibr" rid="pbio.1001056-IhdeScholl1">[29]</xref>, and, possibly, risperidone (the study is inconclusive
                due to the concurrent administration of trazodone <xref ref-type="bibr" rid="pbio.1001056-Lauterbach1">[30]</xref>). These four antidepressant
                drugs all antagonize 5-HT2a and 5-HT2c receptors, and it has been proposed that this
                is at the origin of the trailing phenomenon <xref ref-type="bibr" rid="pbio.1001056-Faber1">[28]</xref>. However, the first recognized
                inducer of visual trails, LSD, has the opposite effect (agonist activity) at both
                these receptors <xref ref-type="bibr" rid="pbio.1001056-Nichols1">[24]</xref>–<xref ref-type="bibr" rid="pbio.1001056-Hintzen1">[26]</xref>. Common to these antidepressant drugs and LSD is an
                increase in extracellular serotonin levels (indeed, all these drugs have been linked
                to serotonin syndrome <xref ref-type="bibr" rid="pbio.1001056-Boyer1">[31]</xref>, a form of poisoning due to excess serotoninergic
                activity that causes a range of symptoms, including hallucinations, elevated body
                temperature, and fast heart beat). Although the evidence is suggestive of a link
                between serotonin and visual trailing, the widespread action of serotonin throughout
                the brain prevents us from speculating further for the time being.</p>
      <p>Visual trails have also been experienced with other drugs with very different
                pharmacology. The antiepileptic drug topiramate, which, among other actions, blocks
                voltage-dependent sodium channels and increases GABA activity at some GABA-A
                receptor subtypes, has been involved with visual trails <xref ref-type="bibr" rid="pbio.1001056-Fontenelle1">[11]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Evans1">[12]</xref>. Increased inhibition, mediated
                by higher levels of serotonin or GABA potentiation, stands out as a likely common
                action of this drug and the ones described previously. Topiramate also inhibits
                cytochrome isoform CYP2D6 <xref ref-type="bibr" rid="pbio.1001056-Benedetti1">[32]</xref>, which has been associated with serotonin syndrome <xref ref-type="bibr" rid="pbio.1001056-Boyer1">[31]</xref>.</p>
      <p>Besides pharmacologically induced trailing, some clinical reports from
                neuropsychological populations deserve to be mentioned. A crisp account of migraine
                patients experiencing trailing is given by Sacks <xref ref-type="bibr" rid="pbio.1001056-Sacks1">[5]</xref>, where he estimates the frequency
                of snapshots at “six to twelve frames per second” (see also <xref ref-type="bibr" rid="pbio.1001056-Sacks2">[33]</xref>). We found one
                other report of visual trails (combined with akinetopsia and palinopsia) in
                migraineurs <xref ref-type="bibr" rid="pbio.1001056-Klee1">[34]</xref>
                (see also medical doctor Klaus Podoll's Web site <xref ref-type="bibr" rid="pbio.1001056-Podoll1">[35]</xref>). On the whole, trailing is a
                very rare disturbance for migraine sufferers, the migraine being a very
                heterogeneous condition that affects roughly 20% of the population at one
                time or another; the possibility exists that the disturbance occurs only for a very
                specific and rare form of migraine, or is a side effect of drugs that patients take
                to relieve their symptoms <xref ref-type="bibr" rid="pbio.1001056-Evans1">[12]</xref>. As a side note of interest, controlled studies have
                found migraine patients to have impairments for global motion perception <xref ref-type="bibr" rid="pbio.1001056-McKendrick1">[36]</xref> (see also
                    <xref ref-type="bibr" rid="pbio.1001056-Granziera1">[37]</xref>).</p>
      <p>A recent case study <xref ref-type="bibr" rid="pbio.1001056-Tsai1">[9]</xref> described visual trails associated with another
                neurological condition: the posterior cortical atrophy variant of Alzheimer's
                disease <xref ref-type="bibr" rid="pbio.1001056-Mendez1">[38]</xref>. The
                symptoms are referred to as akinetopsia/polyopia by the authors, but their
                description corresponds to a direction-specific version of trailing (visual trails
                are perceived when objects move from right to left, but not when they move from left
                to right). Direction-specificity restricts the mechanistic models that can be put
                forward to explain visual trails; however, the etiology is very different from
                previously discussed cases, and in the absence of other reports of directional
                trailing, it is premature to draw conclusions from this report.</p>
      <p>Finally, a very rare disturbance of motion perception, for which Zeki coined the word
                akinetopsia <xref ref-type="bibr" rid="pbio.1001056-Zeki1">[15]</xref>,
                can follow bilateral lesions in the occipito-temporo-parietal cortices <xref ref-type="bibr" rid="pbio.1001056-Zihl1">[39]</xref>. Patient L. M.
                permanently lost motion perception (except for slowly moving objects <xref ref-type="bibr" rid="pbio.1001056-Hess1">[40]</xref>). Instead of
                seeing a moving object, she saw the object in a series of stills, as in a movie run
                too slowly. This is a rather extreme case that differs qualitatively from trailing
                (see <xref ref-type="table" rid="pbio-1001056-t001">Table 1</xref>), but it may
                ultimately rely on similar mechanisms.</p>
    </sec>
    <sec id="s4">
      <title>What May Cause the Perception of Visual Trails?</title>
      <p>Visual trails, because of their discrete and repetitive nature, may represent the
                perceptual manifestation of an underlying periodic process. This periodicity could
                arise outside of the neural system (e.g., eye movements, motor tremor), or may be
                the result of faulty motion computation mechanisms (e.g., motion smear suppression),
                or, finally, may point to a more general, quasi-periodic sampling process that
                affects, among other things, the motion perception system. These three
                (non-exhaustive and non-exclusive) possibilities are developed below.</p>
      <sec id="s4a">
        <title>Do Visual Trails Arise from Abnormal Eye Movements?</title>
        <p>Trailing may not originate in the neural pathways at all. For example, if visual
                    trails are only perceived when subjects track a moving object with their eyes,
                    the discrete afterimages may be caused by a defective, jerky smooth-pursuit
                    mechanism. Saccadic suppression would operate while the eyes execute repeated
                    corrective saccades to keep track of the moving object, shutting on and off the
                    visual input intermittently. Note that people having experienced trailing often
                    recount that trails follow just one or a few moving objects at a time, rather
                    than affecting the entire visual scene, as would be the case after eye movements
                    (or uncontrolled tremors). This makes such a motor explanation unlikely;
                    nonetheless, a well-controlled eye tracking experiment on individuals
                    experiencing visual trails would be essential to evaluate this hypothesis.</p>
      </sec>
      <sec id="s4b">
        <title>Do Visual Trails Reflect a Failure of Specific Motion Perception
                    Mechanisms?</title>
        <p>The periodicity may arise as a disturbance of certain motion processes that are
                    normally continuous. For example, motion streak suppression <xref ref-type="bibr" rid="pbio.1001056-Burr1">[41]</xref> is an
                    inhibitory mechanism allowing the brain to regulate the smear that a moving
                    object leaves in its wake, owing to visible persistence (an image normally takes
                    about 100 ms to fade from perception, long enough to blur the trajectory of a
                    moving object as in a long-exposure photograph). Under the effects of LSD or
                    related drugs, the streak suppression process might fall out of its normal
                    operating range, resulting in stronger than normal local inhibition followed by
                    excitatory rebound. This hypothesis would predict that trailing is accompanied
                    by abnormal oscillatory activity confined within the motion perception system, a
                    prediction that could be verified in human or non-human primates with
                    appropriate recordings.</p>
      </sec>
      <sec id="s4c">
        <title>Could Visual Trails Be the Manifestation of Periodicities Inherent to all
                    Perceptual Processes?</title>
        <p>Trailing may reflect a more widespread rhythmic activity affecting (possibly
                    among other modules) the motion perception system. Two alternatives must be
                    distinguished here, which could be teased apart by comparing oscillatory brain
                    activity in the normal and drug-altered states. Either this rhythmic activity is
                    directly produced by the drug (or at least, increased beyond perceptual
                    threshold)—a rise of inhibition could generate prominent oscillations,
                    turning the normally continuous processing of visual information into a series
                    of discrete snapshots—or this periodicity is always present in the normal
                    brain, but inaccessible to conscious perception. In the latter case, the drug
                    may increase visible persistence, or disrupt motion streak suppression, two
                    processes that would normally serve to hide the discrete visual trails.</p>
      </sec>
    </sec>
    <sec id="s5">
      <title>Related Phenomena Pointing to Periodicities in Visual Perception</title>
      <p>A persistent thread in the perceptual literature is that temporal binning is, indeed,
                common to all of perception (reviewed by <xref ref-type="bibr" rid="pbio.1001056-VanRullen1">[42]</xref>). One of the most striking
                phenomenological manifestations of the discrete nature of perception is the
                so-called “continuous wagon wheel illusion”: in plain sunlight, a
                continuously rotating, spoked wheel can be perceived to rotate in a direction
                opposite to its true motion. While movie watchers are accustomed to this percept
                (which follows from an undersampling of the continuous motion of the wheel by the
                discrete frame rate of the camera and the movie projection system), perceiving
                reversals in conditions of continuous illumination is more challenging.
                Quasi-periodic sampling or binning processes within the visual system have been
                proposed as an explanation; this interpretation has been a subject of controversy,
                and many experiments have been conducted to test it. In light of these recent
                experiments, VanRullen and colleagues hypothesized that attentional processes may
                function in a quasi-periodic manner <xref ref-type="bibr" rid="pbio.1001056-VanRullen2">[43]</xref>,<xref ref-type="bibr" rid="pbio.1001056-VanRullen3">[44]</xref>: when attention is deployed,
                it samples information at discrete moments in time. The rate of sampling may be
                dependent on the task at hand <xref ref-type="bibr" rid="pbio.1001056-VanRullen2">[43]</xref>,<xref ref-type="bibr" rid="pbio.1001056-VanRullen4">[45]</xref>,<xref ref-type="bibr" rid="pbio.1001056-Busch1">[46]</xref>. One component of this theory purports that the attentive
                motion system takes discrete samples of the object in motion to compute its
                trajectory. Past snapshots are usually concealed from conscious perception—but
                some substances may interfere with their proper suppression, giving rise to the
                trailing phenomenon.</p>
    </sec>
    <sec id="s6">
      <title>Towards a Solution: Measuring Visual Trails</title>
      <p>How many “ghost images” <xref ref-type="bibr" rid="pbio.1001056-Kawasaki2">[23]</xref> trail in the wake of the
                moving objects? How far apart are the “discrete and discontinuous
                images” <xref ref-type="bibr" rid="pbio.1001056-Anderson1">[2]</xref>? How long do they persist for? These questions have, so
                far, not been answered. In fact, visual trails have been considered an annoyance at
                best, and quantifying them has not been the main concern in the various clinical
                settings in which they were observed. Careful quantitative investigation will be
                needed to shed light on the mechanisms that cause visual trails to appear as a
                discrete series of snapshots of the moving object.</p>
      <p>As a preliminary step towards quantitative answers, we conducted an online survey in
                which we asked self-declared past LSD users to decide which of ten short movies with
                simulated visual trails best matched their recollected experience. We varied the
                interval between simultaneously perceived snapshots from 25 ms to 250 ms, keeping
                the number of concurrently visible repetitions to four. For over more than 210
                participants, the responses were not randomly distributed across the ten choices,
                but followed a highly consistent pattern (chi-squared test,
                <italic>p</italic>&lt;0.0008) with a preference for faster snapshot periodicities;
                participants selected a time interval between images of 67 ms on average,
                corresponding to an underlying periodicity in the 15–20 Hz (beta) range.
                Although this is the first study that tries to quantitatively assess the frame rate
                of LSD-induced visual trails, it suffers from numerous pitfalls. First, we have
                little control over the individuals who take the survey, as they do so anonymously
                from their home computer. However, this protocol follows a new trend in
                psychological research of using the Web for large-scale studies (see the <ext-link ext-link-type="uri" xlink:href="http://www.testmybrain.org/" xlink:type="simple">http://www.testmybrain.org/</ext-link> Web site recently created by Harvard
                scientists). Second, the responses rely on the memory of the percept, which may be
                faulty. Last, the chemical composition and dose taken by each individual is not
                controlled, which is problematic considering that more than 200 types of LSD tablets
                have been encountered since 1969 and more than 350 blotter paper designs have been
                in circulation since 1975 <xref ref-type="bibr" rid="pbio.1001056-Laing1">[47]</xref> (also, some blotters sold as LSD are in fact mimics). In
                fact, some of the most experienced users indicated that trailing is dose dependent.
                For all these reasons, one must be cautious in interpreting these initial results.
                The movie used for the survey as well as a results summary can be found online at
                    <ext-link ext-link-type="uri" xlink:href="http://www.cerco.ups-tlse.fr/~rufin/lsdsurvey" xlink:type="simple">http://www.cerco.ups-tlse.fr/~rufin/lsdsurvey</ext-link>.</p>
      <p>Collecting further quantitative data with individuals who experience visual trailing
                will be necessary to tease apart the alternative accounts—possibly in
                combination with computational modeling. Solving the mystery of the origins of the
                trailing effect might reveal something deep about the mechanisms underlying
                perception, challenging the way we think we perceive the world.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We wish to thank Christof Koch for useful discussions and comments on the manuscript.
                The Multidisciplinary Association for Psychedelic Studies advertised the survey
                about LSD trails on their Web site (<ext-link ext-link-type="uri" xlink:href="http://www.maps.org/participate/" xlink:type="simple">http://www.maps.org/participate/</ext-link>) and without their help we would
                not have collected as many responses as we did.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pbio.1001056-Asher1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Asher</surname><given-names>H</given-names></name></person-group>
                    <year>1971</year>
                    <article-title>“Trailing” phenomenon–a long-lasting LSD side
                        effect.</article-title>
                    <source>Am J Psychiatry</source>
                    <volume>127</volume>
                    <fpage>1233</fpage>
                    <lpage>1234</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Anderson1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>W. H</given-names></name><name name-style="western"><surname>O'Malley</surname><given-names>J. E</given-names></name></person-group>
                    <year>1972</year>
                    <article-title>Trifluoperazine for the “trailing”
                        phenomenon.</article-title>
                    <source>JAMA</source>
                    <volume>220</volume>
                    <fpage>1244</fpage>
                    <lpage>1245</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Abraham1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>H. D</given-names></name></person-group>
                    <year>1983</year>
                    <article-title>Visual phenomenology of the LSD flashback.</article-title>
                    <source>Arch Gen Psychiatry</source>
                    <volume>40</volume>
                    <fpage>884</fpage>
                    <lpage>889</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Kawasaki1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Kawasaki</surname><given-names>A</given-names></name><name name-style="western"><surname>Purvin</surname><given-names>V. A</given-names></name></person-group>
                    <year>1996</year>
                    <article-title>Persistent palinopsia following ingestion of lysergic acid
                        diethylamide (LSD).</article-title>
                    <source>Arch Ophthalmol</source>
                    <volume>114</volume>
                    <fpage>47</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Sacks1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Sacks</surname><given-names>O</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>In the river of consciousness.</article-title>
                    <source>The New York Review of Books</source>
                    <volume>51</volume>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Kraus1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Kraus</surname><given-names>R</given-names></name></person-group>
                    <year>1996</year>
                    <article-title>Visual “trails” with nefazodone
                        treatment.</article-title>
                    <source>Am J Psychiatry</source>
                    <volume>153</volume>
                    <fpage>1365</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Schwartz1">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>K</given-names></name></person-group>
                    <year>1997</year>
                    <article-title>Nefazodone and visual side effects.</article-title>
                    <source>Am J Psychiatry</source>
                    <volume>154</volume>
                    <fpage>1038</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Horton1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Horton</surname><given-names>J. C</given-names></name><name name-style="western"><surname>Trobe</surname><given-names>J. D</given-names></name></person-group>
                    <year>1999</year>
                    <article-title>Akinetopsia from nefazodone toxicity.</article-title>
                    <source>Am J Ophthalmol</source>
                    <volume>128</volume>
                    <fpage>530</fpage>
                    <lpage>531</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Tsai1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>P. H</given-names></name><name name-style="western"><surname>Mendez</surname><given-names>M. F</given-names></name></person-group>
                    <year>2009</year>
                    <article-title>Akinetopsia in the posterior cortical variant of Alzheimer
                        disease.</article-title>
                    <source>Neurology</source>
                    <volume>73</volume>
                    <fpage>731</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Hughes1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>M. S</given-names></name><name name-style="western"><surname>Lessell</surname><given-names>S</given-names></name></person-group>
                    <year>1990</year>
                    <article-title>Trazodone-induced palinopsia.</article-title>
                    <source>Arch Ophthalmol</source>
                    <volume>108</volume>
                    <fpage>399</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Fontenelle1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Fontenelle</surname><given-names>L. F</given-names></name></person-group>
                    <year>2008</year>
                    <article-title>Topiramate-induced palinopsia.</article-title>
                    <source>J Neuropsychiatry Clin Neurosci</source>
                    <volume>20</volume>
                    <fpage>249</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Evans1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>R. W</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Reversible palinopsia and the Alice in Wonderland syndrome
                        associated with topiramate use in migraineurs.</article-title>
                    <source>Headache</source>
                    <volume>46</volume>
                    <fpage>815</fpage>
                    <lpage>818</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Abert1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <article-title>Abert B, Ilsen PF Palinopsia.</article-title>
                    <source>Optometry</source>
                    <volume>81</volume>
                    <fpage>394</fpage>
                    <lpage>404</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Hoffer1">
        <label>14</label>
        <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Hoffer</surname><given-names>A</given-names></name><name name-style="western"><surname>Osmond</surname><given-names>H</given-names></name></person-group>
                    <year>1967</year>
                    <source>The hallucinogens</source>
                    <publisher-loc>New York</publisher-loc>
                    <publisher-name>Academic Press</publisher-name>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Zeki1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Zeki</surname><given-names>S</given-names></name></person-group>
                    <year>1991</year>
                    <article-title>Cerebral akinetopsia (visual motion blindness). A
                        review.</article-title>
                    <source>Brain</source>
                    <volume>114</volume>
                    <issue>Pt 2</issue>
                    <fpage>811</fpage>
                    <lpage>824</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Bender1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Bender</surname><given-names>M</given-names></name></person-group>
                    <year>1945</year>
                    <article-title>Polyopia and monocular diplopia of cerebral
                        origin.</article-title>
                    <source>Arch Neurol Psychiatry</source>
                    <volume>54</volume>
                    <fpage>323</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Norton1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Norton</surname><given-names>J. W</given-names></name><name name-style="western"><surname>Corbett</surname><given-names>J. J</given-names></name></person-group>
                    <year>2000</year>
                    <article-title>Visual perceptual abnormalities: hallucinations and
                        illusions.</article-title>
                    <source>Semin Neurol</source>
                    <volume>20</volume>
                    <fpage>111</fpage>
                    <lpage>121</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Lopez1">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Lopez</surname><given-names>J</given-names></name><name name-style="western"><surname>Adornato</surname><given-names>B</given-names></name><name name-style="western"><surname>Hoyt</surname><given-names>W. F</given-names></name></person-group>
                    <year>1993</year>
                    <article-title>‘Entomopia’: a remarkable case of cerebral
                        polyopia.</article-title>
                    <source>Neurology</source>
                    <volume>43</volume>
                    <fpage>2145</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Bynke1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Bynke</surname><given-names>H</given-names></name></person-group>
                    <year>1984</year>
                    <article-title>Visual perseveration following temporal-lobe surgery -
                        case-report.</article-title>
                    <source>Neuroophthalmology</source>
                    <volume>4</volume>
                    <fpage>47</fpage>
                    <lpage>53</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Meadows1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Meadows</surname><given-names>J. C</given-names></name><name name-style="western"><surname>Munro</surname><given-names>S. S</given-names></name></person-group>
                    <year>1977</year>
                    <article-title>Palinopsia.</article-title>
                    <source>J Neurol Neurosurg Psychiatry</source>
                    <volume>40</volume>
                    <fpage>5</fpage>
                    <lpage>8</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Smith1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>P. E</given-names></name><name name-style="western"><surname>Shah</surname><given-names>P</given-names></name><name name-style="western"><surname>Sharpe</surname><given-names>J</given-names></name><name name-style="western"><surname>Todd</surname><given-names>A</given-names></name><name name-style="western"><surname>Goringe</surname><given-names>A. P</given-names></name></person-group>
                    <year>2003</year>
                    <article-title>Palinopsia.</article-title>
                    <source>Lancet</source>
                    <volume>361</volume>
                    <fpage>1098</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Ermentrout1">
        <label>22</label>
        <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ermentrout</surname><given-names>B</given-names></name></person-group>
                    <year>1999</year>
                    <article-title>The excited cortex - LSD trails, phosphenes, and other visual
                        confections.</article-title>
                    <comment>Eighth Annual Computational Neuroscience Meeting; Pittsburgh,
                        Pennsylvania; July 1999. Abstracts</comment>
                    <!--===== Restructure page-count as size[@units="page"] =====--><size units="page">201</size>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Kawasaki2">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Kawasaki</surname><given-names>A</given-names></name><name name-style="western"><surname>Purvin</surname><given-names>V</given-names></name></person-group>
                    <year>1996</year>
                    <article-title>Persistent palinopsia following ingestion of lysergic acid
                        diethylamide (LSD).</article-title>
                    <source>Arch Ophthalmol</source>
                    <volume>114</volume>
                    <fpage>47</fpage>
                    <lpage>50</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Nichols1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Nichols</surname><given-names>D. E</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>Hallucinogens.</article-title>
                    <source>Pharmacol Ther</source>
                    <volume>101</volume>
                    <fpage>131</fpage>
                    <lpage>181</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Passie1">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Passie</surname><given-names>T</given-names></name><name name-style="western"><surname>Halpern</surname><given-names>J. H</given-names></name><name name-style="western"><surname>Stichtenoth</surname><given-names>D. O</given-names></name><name name-style="western"><surname>Emrich</surname><given-names>H. M</given-names></name><name name-style="western"><surname>Hintzen</surname><given-names>A</given-names></name></person-group>
                    <year>2008</year>
                    <article-title>The pharmacology of lysergic acid diethylamide: a
                        review.</article-title>
                    <source>CNS Neurosci Ther</source>
                    <volume>14</volume>
                    <fpage>295</fpage>
                    <lpage>314</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Hintzen1">
        <label>26</label>
        <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Hintzen</surname><given-names>A</given-names></name><name name-style="western"><surname>Passie</surname><given-names>T</given-names></name></person-group>
                    <year>2010</year>
                    <source>The pharmacology of LSD: a critical review</source>
                    <publisher-loc>Oxford</publisher-loc>
                    <publisher-name>OUP/Beckley Foundation Press</publisher-name>
                    <!--===== Restructure page-count as size[@units="page"] =====--><size units="page">240</size>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Levi1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Levi</surname><given-names>L</given-names></name><name name-style="western"><surname>Miller</surname><given-names>N. R</given-names></name></person-group>
                    <year>1990</year>
                    <article-title>Visual illusions associated with previous drug
                        abuse.</article-title>
                    <source>J Clin Neuroophthalmol</source>
                    <volume>10</volume>
                    <fpage>103</fpage>
                    <lpage>110</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Faber1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Faber</surname><given-names>R. A</given-names></name><name name-style="western"><surname>Benzick</surname><given-names>J. M</given-names></name></person-group>
                    <year>2000</year>
                    <article-title>Nefazodone-induced palinopsia.</article-title>
                    <source>J Clin Psychopharmacol</source>
                    <volume>20</volume>
                    <fpage>275</fpage>
                    <lpage>276</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-IhdeScholl1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ihde-Scholl</surname><given-names>T</given-names></name><name name-style="western"><surname>Jefferson</surname><given-names>J. W</given-names></name></person-group>
                    <year>2001</year>
                    <article-title>Mitrazapine-associated palinopsia.</article-title>
                    <source>J Clin Psychiatry</source>
                    <volume>62</volume>
                    <fpage>373</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Lauterbach1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Lauterbach</surname><given-names>E. C</given-names></name><name name-style="western"><surname>Abdelhamid</surname><given-names>A</given-names></name><name name-style="western"><surname>Annandale</surname><given-names>J. B</given-names></name></person-group>
                    <year>2000</year>
                    <article-title>Posthallucinogen-like visual illusions (palinopsia) with
                        risperidone in a patient without previous hallucinogen exposure: possible
                        relation to serotonin 5HT2a receptor blockade.</article-title>
                    <source>Pharmacopsychiatry</source>
                    <volume>33</volume>
                    <fpage>38</fpage>
                    <lpage>41</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Boyer1">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Boyer</surname><given-names>E. W</given-names></name><name name-style="western"><surname>Shannon</surname><given-names>M</given-names></name></person-group>
                    <year>2005</year>
                    <article-title>The serotonin syndrome.</article-title>
                    <source>N Engl J Med</source>
                    <volume>352</volume>
                    <fpage>1112</fpage>
                    <lpage>1120</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Benedetti1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Benedetti</surname><given-names>M. S</given-names></name></person-group>
                    <year>2000</year>
                    <article-title>Enzyme induction and inhibition by new antiepileptic drugs: a
                        review of human studies.</article-title>
                    <source>Fundam Clin Pharmacol</source>
                    <volume>14</volume>
                    <fpage>301</fpage>
                    <lpage>319</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Sacks2">
        <label>33</label>
        <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Sacks</surname><given-names>O. W</given-names></name></person-group>
                    <year>1999</year>
                    <source>Migraine</source>
                    <publisher-loc>New York</publisher-loc>
                    <publisher-name>Vintage Books</publisher-name>
                    <fpage/>
                    <page-range>368</page-range>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Klee1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Klee</surname><given-names>A</given-names></name><name name-style="western"><surname>Willanger</surname><given-names>R</given-names></name></person-group>
                    <year>1966</year>
                    <article-title>Disturbances of visual perception in migraine review of the
                        literature and a report of eight cases.</article-title>
                    <source>Acta Neurologica Scandinavica</source>
                    <volume>42</volume>
                    <fpage>400</fpage>
                    <lpage>414</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Podoll1">
        <label>35</label>
        <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Podoll</surname><given-names>K</given-names></name></person-group>
                    <year>2007</year>
                    <article-title>Migrane Aura Foundation.</article-title>
                    <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.migraine-aura.org" xlink:type="simple">http://www.migraine-aura.org</ext-link>. Accessed 4 April
                        2011</comment>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-McKendrick1">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>McKendrick</surname><given-names>A. M</given-names></name><name name-style="western"><surname>Badcock</surname><given-names>D. R</given-names></name><name name-style="western"><surname>Badcock</surname><given-names>J. C</given-names></name><name name-style="western"><surname>Gurgone</surname><given-names>M</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Motion perception in migraineurs: abnormalities are not related
                        to attention.</article-title>
                    <source>Cephalalgia</source>
                    <volume>26</volume>
                    <fpage>1131</fpage>
                    <lpage>1136</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Granziera1">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Granziera</surname><given-names>C</given-names></name><name name-style="western"><surname>DaSilva</surname><given-names>A. F. M</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>J</given-names></name><name name-style="western"><surname>Tuch</surname><given-names>D. S</given-names></name><name name-style="western"><surname>Hadjikhani</surname><given-names>N</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Anatomical alterations of the visual motion processing network in
                        migraine with and without aura.</article-title>
                    <source>PLoS Med</source>
                    <volume>3</volume>
                    <fpage>e402</fpage>
                    <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0030402" xlink:type="simple">10.1371/journal.pmed.0030402</ext-link></comment>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Mendez1">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Mendez</surname><given-names>M. F</given-names></name><name name-style="western"><surname>Ghajarania</surname><given-names>M</given-names></name><name name-style="western"><surname>Perryman</surname><given-names>K. M</given-names></name></person-group>
                    <year>2002</year>
                    <article-title>Posterior cortical atrophy: clinical characteristics and
                        differences compared to Alzheimer's disease.</article-title>
                    <source>Dement Geriatr Cogn Disord</source>
                    <volume>14</volume>
                    <fpage>33</fpage>
                    <lpage>40</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Zihl1">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Zihl</surname><given-names>J</given-names></name><name name-style="western"><surname>Von Cramon</surname><given-names>D</given-names></name><name name-style="western"><surname>Mai</surname><given-names>N</given-names></name></person-group>
                    <year>1983</year>
                    <article-title>Selective disturbance of movement vision after bilateral brain
                        damage.</article-title>
                    <source>Brain</source>
                    <volume>106</volume>
                    <fpage>313</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Hess1">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Hess</surname><given-names>R</given-names></name><name name-style="western"><surname>Baker</surname><given-names>C. L</given-names></name><name name-style="western"><surname>Zihl</surname><given-names>J</given-names></name></person-group>
                    <year>1989</year>
                    <article-title>The “motion-blind” patient: low-level spatial and
                        temporal filters.</article-title>
                    <source>J Neurosci</source>
                    <volume>9</volume>
                    <fpage>1628</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Burr1">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Burr</surname><given-names>D</given-names></name></person-group>
                    <year>1980</year>
                    <article-title>Motion smear.</article-title>
                    <source>Nature</source>
                    <volume>284</volume>
                    <fpage>164</fpage>
                    <lpage>165</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-VanRullen1">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>VanRullen</surname><given-names>R</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C</given-names></name></person-group>
                    <year>2003</year>
                    <article-title>Is perception discrete or continuous?</article-title>
                    <source>Trends Cogn Sci</source>
                    <volume>7</volume>
                    <fpage>207</fpage>
                    <lpage>213</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-VanRullen2">
        <label>43</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>VanRullen</surname><given-names>R</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>L</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C</given-names></name></person-group>
                    <year>2005</year>
                    <article-title>Attention-driven discrete sampling of motion
                        perception.</article-title>
                    <source>Proc Natl Acad Sci U S A</source>
                    <volume>102</volume>
                    <fpage>5291</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-VanRullen3">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>VanRullen</surname><given-names>R</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>L</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>The continuous wagon wheel illusion is associated with changes in
                        electroencephalogram power at approximately 13 Hz.</article-title>
                    <source>J Neurosci</source>
                    <volume>26</volume>
                    <fpage>502</fpage>
                    <lpage>507</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-VanRullen4">
        <label>45</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>VanRullen</surname><given-names>R</given-names></name><name name-style="western"><surname>Carlson</surname><given-names>T</given-names></name><name name-style="western"><surname>Cavanagh</surname><given-names>P</given-names></name></person-group>
                    <year>2007</year>
                    <article-title>The blinking spotlight of attention.</article-title>
                    <source>Proc Natl Acad Sci U S A</source>
                    <volume>104</volume>
                    <fpage>19204</fpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Busch1">
        <label>46</label>
        <element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Busch</surname><given-names>N. A</given-names></name><name name-style="western"><surname>VanRullen</surname><given-names>R</given-names></name></person-group>
                    <year>2010</year>
                    <article-title>Spontaneous EEG oscillations reveal periodic sampling of visual
                        attention.</article-title>
                    <source>Proc Natl Acad Sci U S A</source>
                    <volume>107</volume>
                    <fpage>16048</fpage>
                    <lpage>16053</lpage>
                </element-citation>
      </ref>
      <ref id="pbio.1001056-Laing1">
        <label>47</label>
        <element-citation publication-type="other" xlink:type="simple">
                    <person-group person-group-type="editor"><name name-style="western"><surname>Laing</surname><given-names>R. R</given-names></name></person-group>
                    <year>2003</year>
                    <source>Hallucinogens: a forensic drug handbook</source>
                    <publisher-loc>San Diego</publisher-loc>
                    <publisher-name>Academic Press.</publisher-name>
                </element-citation>
      </ref>
    </ref-list>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>LSD</term>
          <def>
            <p>lysergic acid diethylamid</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    
  </back>
</article>